 |
|
Risk Factors for Cardiovascular Disease in Women
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: In the study of risk factors for cardiovascular disease in women by Dr Ridker and colleagues,1 274 (59%) of the 464 outcome events were coronary revascularizations. However, there was no presentation of data related to all-cause mortality.
When lipid-related risk is being studied, overall mortality becomes an important outcome because there is evidence that statins do not reduce mortality in women with heart disease.2 Moreover, in a large population study including men and women, patients who were older than 50 years and who were in the lowest quartiles for cholesterol had significantly increased mortality that, in women, equaled the risk of smoking.3 The article cited by the authors on the Air Force/Texas Coronary Atherosclerosis Prevention Study4 of lovastatin is indeed indicative of an event-based benefit, but the study concluded with numerically more deaths in patients who took the drug than in those who took the placebo.5
Because . . . [Full Text of this Article]
Eddie Vos, MEng
vos@health-heart.org
Sutton, Quebec
Colin P. Rose, MD
Department of Medicine
McGill University
Montreal, Quebec
RELATED ARTICLES
Risk Factors for Cardiovascular Disease in Women
Allan D. Sniderman
JAMA. 2005;294(22):2843-2844.
EXTRACT
| FULL TEXT
Risk Factors for Cardiovascular Disease in Women—Reply
Paul M Ridker and Julie E. Buring
JAMA. 2005;294(22):2844.
EXTRACT
| FULL TEXT
Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women
Paul M Ridker, Nader Rifai, Nancy R. Cook, Gary Bradwin, and Julie E. Buring
JAMA. 2005;294(3):326-333.
ABSTRACT
| FULL TEXT
|
